(Q40718956)

English

Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis

scientific article published on May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

author name string

Natacha Bessis

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Virginie Cottard

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Nathalie Saidenberg-Kermanach

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Delphine Lemeiter

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Catherine Fournier

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Marie-Christophe Boissier

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Journal of Gene Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

300-307

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Autoimmunity to type II collagen an experimental model of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Gene therapy for rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA).

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Experimental autoimmune arthritis in mice. II. Early events in the elicitation of the autoimmune phenomenon induced by homologous type II collagen.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Gene transfer to synoviocytes: prospects for gene treatment of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Adenoviral-mediated gene transfer to rabbit synovium in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Immunisation against heterologous type II collagen induces arthritis in mice

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Arthritogenicity of minor cartilage collagens (types IX and XI) in mice

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice

1 reference

https://api.crossref.org/works/10.1002%2FJGM.275

21 January 2018

Identifiers

10.1002/JGM.275

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

release_atub26laara7le23vors5ydqh4

1 reference

https://api.fatcat.wiki/v0/release/atub26laara7le23vors5ydqh4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40718956&oldid=1905133159"